Advertisement

HindustanTimes Sat,12 Jul 2014

Dr Reddy's Q3 net dips 29% to Rs.363.3 cr

HT Correspondent, Hindustan Times  Mumbai, February 14, 2013
First Published: 22:24 IST(14/2/2013) | Last Updated: 22:25 IST(14/2/2013)

Drug maker Dr Reddy's Laboratories on Thursday announced a decline of 29% year-on-year in its net profit to Rs.363.3 crore for the third quarter ended December 2012 against Rs.512.96 crore a year ago.

Advertisement

The company's research and development expenses rose 34% to Rs.203 crore while selling general and administrative expenses were up over 11.5% at Rs.857 crore.

Its shares declined 1% to close at Rs.1,878 on the BSE.


Advertisement
more from Business

Doubling of tax on debt mutual funds to hit retirees

On Thursday, finance minister Arun Jaitley gave investors and the mutual fund industry a jolt by increasing the long-term capital gains tax on debt mutual funds to 20% from 10%. The definition of long-term has also been changed to 36 months for non-equity MFs from 12 months.
markets
Advertisement
Most Popular
Advertisement
Advertisement
Copyright © 2014 HT Media Limited. All Rights Reserved